v3.26.1
Consolidated Schedule of Investments
3 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Investment Holdings [Text Block]

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments

 

March 31, 2026 (UNAUDITED)

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST

BASIS

  

VALUE

 

INTRAOP MEDICAL CORP.

                   

((0.2%))
Medical Devices

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/11/2019

  500,000  $500,000  $13 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/22/2021

  1,000,000   1,000,000   27 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/29/2019

  500,000   500,000   13 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/6/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

11/12/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

11/29/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

12/31/2018

  10,961,129   10,961,129   297 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

2/27/2020

  1,000,000   1,000,000   27 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

2/28/2022

  200,000   200,000   5 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

3/25/2020

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

3/30/2022

  150,000   150,000   4 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

3/8/2020

  400,000   400,000   11 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

4/20/2021

  1,000,000   1,000,000   27 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

4/6/2022

  350,000   350,000   9 

 

 

See accompanying notes to financial statements

 

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST

BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

                   
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

6/10/2021

  500,000  $500,000  $14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

6/10/2022

  700,000   700,000   19 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

7/12/2019

  1,300,000   1,300,000   35 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

7/16/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

7/31/2020

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

8/28/2020

  750,000   750,000   20 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

9/22/2021

  500,000   500,000   14 
 

Preferred Stock *(1)(2)(4)

     

7/12/2013

  26,856,187   26,299,939   0 
 

Term Note (1)(2)(4)(6)

12/31/2026  8%

2/10/2017

  2,000,000   2,000,000   54 
 

Term Note (1)(2)(4)(6)

12/31/2026  8%

2/28/2014

  3,000,000   3,000,000   81 
                  754 
                    

LYNCEAN TECHNOLOGIES, INC.
(0.0%)
Semiconductor Equipment

Preferred Stock - Series B *(1)(4)

     

7/3/2018

  869,792   1,000,000   0 
                    

REVASUM, INC.
(0.0%)
Semiconductor Equipment

CDIs *(2)(4)

     

11/14/2016 - 10/3/2022

  39,774,889   9,268,219   0 

 

 

 

See accompanying notes to financial statements

 

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

ACQUISITION
DATE

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

UCT COATINGS, INC.
((32.3%))
Advanced Materials

Common Stock *(1)(3)(4)

  

4/18/2011

1,500,000

 $

662,235

 $

 

143,560

 
             

WRIGHTSPEED, INC.

            

(0.0%)
Automotive

Common Stock *(1)(2)(4)

  

6/7/2019

69,102

  

7,460,850

  

0

 
 

Preferred Stock *(1)(2)(4)

6/7/2019-

7/20/2020

60,733,693

  

17,355,887

  

0

 
           

0

 
             

INVESTMENT COMPANY
((0.5%))

Fidelity Investments Money Market Treasury Portfolio - Class I 3.55% (5)(7)

  

Various

2,116

  

2,116

  

2,116

 
             

TOTAL INVESTMENTS
(Cost $89,860,375)
— (33.0%)

          

146,430

 

OTHER LIABILITIES IN EXCESS OF OTHER ASSETS — 133.0%

          

(590,487

)

NET ASSETS — 100.0%

         $

(444,057

)
             

 

All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

 

CDI:  CHESS Depositary Interests.
  

*

Non-income producing security.

(1)

Restricted security. Fair Value is determined in good faith by Firsthand Capital Management, Inc. ("FCM" or the "Advisor") as the valuation designee under Rule 2a-5 under the 1940 Act, subject to oversight by the Board (see Note 3). At March 31, 2026, we held $144,314 (or (32.5)% of net assets) in restricted securities (see Note 2).

(2)

Controlled investments.

(3)

Affiliated issuer.

(4)

Fair Value Level 3 security (-32.5% of net assets).

(5)

The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

(6)

Security whose interest accrues until maturity however, based on March 31, 2026 valuation no such interest accrued during period ended March 31, 2026.

(7)

The rate shown is the 7 day annualized yield at March 31, 2026.

 

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2025

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

 

COST BASIS

 

VALUE

 

INTRAOP MEDICAL CORP.

                

((0.6%))
Medical Devices

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/11/2019

  

500,000

 

$

500,000

 

$

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/22/2021

  

1,000,000

  

1,000,000

  

55

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/29/2019

  

500,000

  

500,000

  

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/6/2021

  

500,000

  

500,000

  

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

11/12/2021

  

500,000

  

500,000

  

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

11/29/2021

  

500,000

  

500,000

  

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

12/31/2018

  

10,961,129

  

10,961,129

  

600

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

2/27/2020

  

1,000,000

  

1,000,000

  

55

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

2/28/2022

  

200,000

  

200,000

  

11

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

3/25/2020

  

500,000

  

500,000

  

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

3/30/2022

  

150,000

  

150,000

  

8

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

3/8/2020

  

400,000

  

400,000

  

22

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

4/20/2021

  

1,000,000

  

1,000,000

  

55

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

4/6/2022

  

350,000

  

350,000

  

19

 

 

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2025

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST RATE

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

                    
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

6/10/2021

  

500,000

  

$

500,000

  

$

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

6/10/2022

  

700,000

   

700,000

   

38

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

7/12/2019

  

1,300,000

   

1,300,000

   

71

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

7/16/2021

  

500,000

   

500,000

   

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

7/31/2020

  

500,000

   

500,000

   

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

8/28/2020

  

750,000

   

750,000

   

41

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

9/22/2021

  

500,000

   

500,000

   

27

 
 

Preferred Stock - Series C *(1)(2)(4)

      

7/12/2013

  

26,856,187

   

26,299,939

   

0

 
 

Term Note (1)(2)(4)(6)

12/31/2026 

8

%

  

2/10/2017

  

2,000,000

   

2,000,000

   

110

 
 

Term Note (1)(2)(4)(6)

12/31/2026 

8

%

  

2/28/2014

  

3,000,000

   

3,000,000

   

164

 
                   

1,523

 
                     

LYNCEAN TECHNOLOGIES, INC.
(0.0%)
Semiconductor Equipment

Preferred Stock - Series B *(1)(4)

      

7/3/2018

  

869,792

   

1,000,000

   

0

 
                     

REVASUM, INC.
(0.0%)
Semiconductor Equipment

CDIs *(2)(4)

    11/14/2016-

10/3/2022

  

39,774,889

   

9,268,218

   

0

 

 

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2025

 

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

ACQUISITION
DATE

 

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

UCT COATINGS, INC.
((71.3%))
Advanced Materials

Common Stock *(1)(3)(4)

  

4/18/2011

  

1,500,000

  

$

662,235

  

$

167,642

 
                 

WRIGHTSPEED, INC.

                

(0.0%)
Automotive

Common Stock *(1)(2)(4)

  

6/7/2019

  

69,102

   

7,460,851

   

0

 
 

Preferred Stock - Series AA *(1)(2)(4)

6/7/2019-

 7/20/2020

  

60,733,693

   

17,355,887

   

0

 
               

0

 
                 

INVESTMENT COMPANY
((23.9%))

Fidelity Investments Money Market Treasury Portfolio - Class I 3.66%(5)(7)

  

Various

  

56,271

   

56,271

   

56,271

 
                 

TOTAL INVESTMENTS
(Cost $89,914,530)
— (95.8%)

          

225,436

 

OTHER LIABILITIES IN EXCESS OF OTHER ASSETS — 195.8%

          

(460,564

)

NET ASSETS — 100.0%

         

$

(235,128

)

 

All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

 

CDI:

CHESS Depositary Interests.

  
  

*

Non-income producing security.

(1)

Restricted security. Fair Value is determined in good faith by Firsthand Capital Management, Inc. ("FCM" or the "Advisor") as the valuation designee under Rule 2a-5 under the 1940 Act, subject to oversight by the Board (see Note 3). At December 31, 2025, we held $169,165 or (71.9)% of net assets) in restricted securities (see Note 2).

(2)

Controlled investments.

(3)

Affiliated issuer.

(4)

Fair Value Level 3 security (-71.9% of net assets).

(5)

The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

(6)

Security whose interest accrues until maturity however, based on December 31, 2025 valuation no such interest accrued during period ended December 31, 2025.

(7)

The rate shown is the 7 day annualized yield at December 31, 2025

 

 

See accompanying notes to financial statements